Updates in CRC: Applying Evidence to Clinical Practice - Episode 6

Exploring the NICHE-2 Trial: Neoadjuvant Immunotherapy in dMMR Colon Cancer

Panelists discuss how the NICHE-2 trial results demonstrate the potential benefits and implementation of neoadjuvant immunotherapy in patients with dMMR colon cancer, highlighting pathologic response rates and implications for treatment sequencing.